Showing 1331-1340 of 10904 results for "".
- Ultra-Processed Foods May Influence Pediatric Acne Through mTORC1 Signaling: Studyhttps://practicaldermatology.com/news/ultra-processed-foods-may-influence-pediatric-acne-through-mtorc1-signaling-study/2488415/Ultra-processed foods may contribute to pediatric acne through metabolic, inflammatory, and microbiome-related pathways, according to a comprehensive review published in the International Journal of Molecular Sciences. Researchers examined current evidence connecting ultra-processed foods
- Omalizumab Shows Median 3.1-Year Drug Survival in Chronic Urticariahttps://practicaldermatology.com/news/omalizumab-shows-median-31-year-drug-survival-in-chronic-urticaria/2488414/Omalizumab demonstrated a median drug survival of more than 3 years among patients with chronic urticaria (CU), with successful disease control rather than adverse events emerging as a common reason for treatment discontinuation, according to a systematic review an
- PISCES: Adalimumab Biosimilar Achieves PASI75 in 81% of Children With Severe Psoriasishttps://practicaldermatology.com/news/pisces-adalimumab-biosimilar-achieves-pasi75-in-81-of-children-with-severe-psoriasis/2488405/The first prospective study of an adalimumab biosimilar in Chinese children with severe plaque psoriasis showed significant clinical response through 16 weeks and no reported adverse events. The multicenter PISCES study, published in Dermatology and Therapy, included 80 patients a
- PCA SKIN Launches Acne Control Prebiotic Gel Cleanserhttps://practicaldermatology.com/news/pca-skin-launches-acne-control-prebiotic-gel-cleanser/2488391/PCA SKIN has launched Acne Control Prebiotic Gel Cleanser, a daily cleanser designed for acne-prone skin that pairs acne-fighting ingredients with technology intended to support the skin microbiome. The gel-to-lather cleanser contains 2% salicylic acid to help clear and prevent acne breako
- AI Analysis Maps Environmental and Immune Signatures in Pediatric ADhttps://practicaldermatology.com/news/ai-analysis-maps-environmental-and-immune-signatures-in-pediatric-atopic-dermatitis/2488367/A machine learning (ML)-based analysis of environmental, immune, and transcriptomic data identified distinct protective and susceptibility clusters associated with pediatric atopic dermatitis (AD) among AmaXhosa children in South Africa. Published in PLoS Medicine, the observation
- DRESS: Tofacitinib Shows Glucocorticoid-Sparing Potentialhttps://practicaldermatology.com/news/dress-tofacitinib-shows-glucocorticoid-sparing-potential/2488346/Adding tofacitinib to systemic glucocorticoid therapy was associated with reduced glucocorticoid exposure and faster clinical improvement among patients with drug reaction with eosinophilia and systemic symptoms (DRESS), according to a study published online in the
- Consensus Statement: JAK Inhibitors Emerge as Primary Therapy for Severe Alopeciahttps://practicaldermatology.com/news/consensus-statement-jak-inhibitors-emerge-as-primary-therapy-for-severe-alopecia/2488332/A US expert consensus provides a standardized treatment framework for adults with severe alopecia areata (AA), placing oral Janus kinase (JAK) inhibitors at the center of long-term disease management.
- Cardamonin Shows Antifibrotic Activity in Human Keloid Fibroblasts: Studyhttps://practicaldermatology.com/news/cardamonin-shows-antifibrotic-activity-in-human-keloid-fibroblasts-study/2488327/Cardamonin demonstrated antifibrotic activity in human keloid fibroblasts by suppressing transforming growth factor β1 (TGF-β1)/Smad signaling, according to new in vitro research in the Journal of Drugs in Dermatology.
- Daily SPF Use Lags Among Youth: Surveyhttps://practicaldermatology.com/news/daily-spf-use-lags-among-youth-in-multigenerational-skincare-survey/2488298/Interest in facial skincare is growing among children and adolescents, new findings suggest. Researchers evaluated a 3-product regimen consisting of a hydrating cream cleanser, hydrating moisturizer, and daily mineral SPF 40
- Upadacitinib Shows Sustained Responses in PsA After Prior TNF Inhibitor: Analysishttps://practicaldermatology.com/news/upadacitinib-shows-sustained-responses-in-psa-after-prior-tnf-inhibitor-analysis/2488287/A post hoc analysis of SELECT-PsA 2 found sustained responses with upadacitinib 15 mg once daily through 152 weeks among patients with psoriatic arthritis (PsA) previously exposed to 1 tumor necrosis factor inhibitor (TNFi). Published in RMD Open, the analysis included 195 patient